Cited by 450Genetic Associations and EpidemiologyCerebrovascular and genetic disordersGenetic Mapping and Diversity in Plants and Animals

A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression

Open access
Gupta, Rajat M., Hadaya, Joseph, Trehan, Aditi, Zekavat, Seyedeh M., Roselli, Carolina, Klarin, Derek, Emdin, Connor A., Hilvering, Catharina R.E. +13 more·2017·Cell

Abstract

Genome-wide association studies (GWASs) implicate the PHACTR1 locus (6p24) in risk for five vascular diseases, including coronary artery disease, migraine headache, cervical artery dissection, fibromuscular dysplasia, and hypertension. Through genetic fine mapping, we prioritized rs9349379, a common SNP in the third intron of the PHACTR1 gene, as the putative causal variant. Epigenomic data from human tissue revealed an enhancer signature at rs9349379 exclusively in aorta, suggesting a regulatory function for this SNP in the vasculature. CRISPR-edited stem cell-derived endothelial cells demonstrate rs9349379 regulates expression of endothelin 1 (EDN1), a gene located 600 kb upstream of PHACTR1. The known physiologic effects of EDN1 on the vasculature may explain the pattern of risk for the five associated diseases. Overall, these data illustrate the integration of genetic, phenotypic, and epigenetic analysis to identify the biologic mechanism by which a common, non-coding variant can distally regulate a gene and contribute to the pathogenesis of multiple vascular diseases.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2017.06.049

Cites

Statistics

Nothing to recompute.

Claims the paper makes

0 of 14 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    EDN1 expression was 50-fold higher in ECs than in VSMCs.

    “Though EDN1 expression was differentially regulated in both ECs and VSMCs, there was a 50-fold higher expression in ECs (Figure S3C).”
    Quote in the paperNot a substantial claim
  • Findingown data

    WT and Δ88 iPSCs differentiated into neural crest progenitor cells showed no differential gene expression.

    “There was no differential gene expression between wild-type (WT) and Δ88 iPSCs differentiated to a non-vascular cell type, neural crest progenitor cells (Figure S3B).”
    Quote in the paperSubstantial claim
  • Findingown data

    Human tissue epigenomic data showed an enhancer mark at rs9349379 only in aorta.

    “Epigenomic data from human tissue revealed an enhancer signature at rs9349379 exclusively in aorta, suggesting a regulatory function for this SNP in the vasculature.”
    • Also stated in: § A Vascular-Specific Regulatory Region at rs9349379 · plain
      “In these aortic samples, a strong enhancer signal overlies rs9349379 (Figure 2B), spanning 1 kb.”
    Quote in the paperSubstantial claim
  • Findingown data

    In the UK Biobank PheWAS, rs9349379 showed no significant association with any other diseases.

    “There was no significant association of rs9349379 with any other diseases in the UK Biobank PheWAS (Figure S1C).”
    Quote in the paperSubstantial claim
  • Findingown data

    Gene set enrichment analysis showed strong enrichment for blood vessel development (FDR=1.64e-10), vasculature development (FDR=2.98e-10), and blood vessel morphogenesis (FDR=2.21e-9).

    “Gene set enrichment analysis of the differentially expressed genes showed strong enrichment for blood vessel development (FDR = 1.64 × 10−10), vasculature development (FDR = 2.98 × 10−10), and blood vessel morphogenesis (FDR = 2.21 × 10−9).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. 19
  • May combine two claims. 17
  • The quote only partly states this claim. 3
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    TBC1D7 expression differed by qPCR (p=1.75e-5), but this was not seen in RNA-seq from separately differentiated cells or in Δ88 deletions.

    “There was a significant difference in TBC1D7 expression by qPCR (p = 1.75 × 10−5); however, this was not seen in the RNA-seq quantification from separately differentiated cells or the Δ88 deletions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Most differentially expressed transcripts had log2 fold changes below 1.5 (243 of 279, 87%).

    “The majority of these differentially expressed transcripts had log2 fold changes <1.5 (243/279,87%; Figure S4D).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The rs9349379 G allele, at 36% frequency, raises risk for CAD and coronary calcification but lowers risk for migraine, cervical artery dissection, fibromuscular dysplasia, and hypertension.

    “The pattern of association is striking as the minor allele at rs9349379 (G, 36% frequency) leads to increased risk for CAD and coronary calcification but decreased risk for four conditions (migraine headache, cervical artery dissection, fibromuscular dysplasia, and hypertension).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    ESC-derived ECs reproduced the regulatory effect, with Δ88 ESC-ECs showing higher EDN1 expression than WT ESC-ECs (p=0.0004).

    “ESC-derived ECs confirmed the regulatory effect, and Δ88 ESC-ECs demonstrated higher expression compared with WT ESC-ECs (Figure 3C; p = 0.0004).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
  • May combine two claims.

    Findingown data

    At 6p24, rs9349379 had the strongest association signal, with p=1.81e-42 and OR=1.14, stronger than the next SNP rs78145402 (OR=1.08, p=4.69e-17).

    “The strongest association was for a single variant, rs9349379, with an association of 1.81 × 10−42 (odds ratio [OR] = 1.14), far exceeding the association signal for the next most highly associated SNP, rs78145402 (OR = 1.08, 4.69 × 10−17).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In Δ88 RNA-seq, the top pathways were blood vessel development (FDR=2.6e-7) and blood vessel morphogenesis (FDR=2.6e-7).

    “The top pathways were also blood vessel development (FDR = 2.6 × 10∼7) and blood vessel morphogenesis (FDR = 2.6 × 10−7).”
    Quote in the paperNot a substantial claim
  • The quote only partly states this claim.

    Findingown data

    In 16,662 participants, the rs9349379 G allele was associated with lower flow-mediated vasodilation (β=-0.1209; 95% CI -0.5535 to -0.6188; p=0.004).

    “The G allele at rs9349379 was associated with decreased flow-mediated vasodilation (β = −0.1209 [95% CI: −0.5535, −0.6188], p = 0.004).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    RNA-seq comparing A/A and G/G ESC-ECs found 279 differentially expressed transcripts at FDR<0.05, with samples clustering by rs9349379 genotype.

    “We found 279 differentially expressed (false discovery rate [FDR] < 0.05) transcripts, with clustering of samples according to rs9349379 genotype as expected (Figure 4B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    qPCR confirmed the RNA-seq expression differences and showed a cis-regulatory effect of rs9349379 genotype on EDN1, with the minor allele increasing EDN1 (p=7.59e-7).

    “The qPCR confirmed the differential gene expression seen by RNA-seq, and it demonstrated a cis-regulatory effect of genotype at rs9349379 on EDN1 expression, with the minor allele driving increased EDN1 expression (Figure 4D; p = 7.59 × 10−7).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    rs9349379 was associated with systolic blood pressure but not with lipids, weight, diabetes, or other related measures.

    “Analysis for association between rs9349379 and cardiovascular risk factors confirmed the previously reported association with systolic blood pressure, but no relationship with lipid concentrations, weight, diabetes, or other related measures (Figure S1B, data obtained from analysis of multiple studies listed in Table S3).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Sex had no significant effect on ET-1 expression (p=0.26).

    “There was no significant effect of sex on ET-1 expression (Figure S6; p = 0.26).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    4C-seq showed very low contact probability and no focal loop between rs9349379 and the EDN1 promoter.

    “4C-seq revealed a very low contact probability and no evidence for a focal loop between rs9349379 and the EDN1 promoter (Figure 5A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In VSMCs, EDN1 was the only differentially expressed transcript in the 6p24 locus (p=0.012), and its expression was 50-fold lower than in ECs.

    “EDN1 was the only differentially expressed transcript in the 6p24 locus (Figure 4F; p = 0.012) in VSMCs; however, the level of EDN1 expression was 50-fold lower in VSMCs than in ECs.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    COL4A1, COL3A1, and FN1 may be downstream consequences of higher EDN1 expression in G/G ESC-ECs.

    “The differentially regulated genes included several mediators of vascular wall integrity and structure, such as COL4A1, COL3A1, and FN1 (Figure S4E), which may be downstream effects of increased EDN1 expression in the G/G ESC-ECs (Amiri et al., 2004; Shi-Wen et al., 2001).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Amiri et al., 2004

      Not checked in the free run.

    • cites Shi-Wen et al., 2001

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    In both deletion and allelic-series EC RNA-seq, rs9349379 regulatory effects fell in vascular development pathways and may be explained by its cis effect on EDN1.

    “In RNA-seq from both the deletion and allelic series ECs, the regulatory effects of rs9349379 localized to vascular development pathways, and they may be explained by the cis-regulatory effect on EDN1 expression.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    All luciferase reporter constructs were confirmed by Sanger sequencing of the plasmids.

    “All constructs were verified by Sanger sequencing of plasmids.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Plasma BigET-1 levels were analyzed with an additive linear regression model that included sex and age as covariates.

    “Human plasma BigET-1 levels were analyzed using additive model of linear regression with sex and age as co-variates.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Plasma samples were restricted to individuals with a Charlson Comorbidity Score of 0 who were not using antihypertensive medications.

    “Samples were limited to those with Charlson Comorbidity Scores of 0, and individuals not taking any antihypertensive medications.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    RNA sequencing was carried out on samples with an RNA integrity number of 10.

    “RNA-sequencing was conducted on samples with RIN of 10 (Agilent Technologies).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The rs9349379 G allele is associated with lower risk of migraine, cervical artery dissection, and fibromuscular dysplasia, three conditions that co-occur epidemiologically.

    “The G allele at rs9349379 is associated with decreased risk for migraine headache, cervical artery dissection, and fibromuscular dysplasia—three diseases that co-occur epidemiologically (Olin et al., 2014; Pezzini et al., 2005; Rubinstein et al., 2005).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Olin et al., 2014

      Not checked in the free run.

    • cites Pezzini et al., 2005

      Not checked in the free run.

    • cites Rubinstein et al., 2005

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductown data

    In the analysis of phenotypic associations, the study adjusted for age, sex, ten principal components of ancestry, and genotyping array type when testing rs9349379 against 36 diseases.

    “Phenotypic associations were analyzed using logistic regression, adjusting for age, sex, ten principal components of ancestry and a dummy variable for the array type used in genotyping, was used to test for the presence of association between rs9349379 and each of the 36 different diseases.”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Interpretationown data

    The plasma analysis adds human-sample support for an association between rs9349379 and the vasoactive ET-1 peptide.

    “This analysis provides further support in human samples of the association between rs93493979 and the vasoactive ET-1 peptide.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Real-time PCR experiments were performed on three independently differentiated cell clones, with three technical replicates per clone.

    “All experiments used 3 separately differentiated cellular clones, and differentiation was conducted in parallel. Data represent the average of three technical replicates per clone, and statistical analysis on three independently differentiated clones (n = 3).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    The genetic findings suggest that migraine, dissection, and fibromuscular dysplasia may share pathophysiology through one or more downstream ET-1 effects, though further investigation is needed.

    “The genetic data suggest the shared pathophysiology of migraine, dissection, and fibromuscular dysplasia may occur through one or more of these downstream effects of ET-1, though this requires further investigation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The data fit a physiology in which the G allele raises EDN1 expression, increases ET-1 binding to ETA on VSMCs, causes vasoconstriction, and thereby lowers migraine risk.

    “Our data are consistent with this physiology, as the G allele at rs9349379 results in higher EDN1 expression, increased ET-1 binding to the ETA receptor on VSMCs, vasoconstriction, and, therefore, reduced risk of migraine headache.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
    • Rests on an assumption: A roughly 20% change in EDN1 expression caused by rs9349379 is large enough to influence risk of the five vascular diseases.
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    Genomic deletions were checked by agarose gel electrophoresis and validated by Sanger sequencing.

    “Genomic deletions were screened for with agarose gel electrophoresis of PCR amplicons and confirmed with Sanger sequencing of PCR amplicons.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    To control for Cas9 off-target effects, three wild-type and three mutant clones for each intended mutation were expanded.

    “To account for off-target effects of the Cas9 nuclease, 3 wild-type and 3 clones with each desired mutations were expanded.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. The quote only partly states this claim.

    Study design and conductown data

    RNA sequencing was performed on endothelial cells derived from three homozygous major and three homozygous minor stem cell lines.

    “3 homozygous major (A/A) and 3 homozygous minor (G/G) stem cell lines were differentiated into ECs as described above.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    The study used a Bonferroni-corrected significance threshold of 0.0014, derived from 0.05 divided by 36.

    “A Bonferroni-adjusted p value of 0.0014 (0.05/36) was used as the threshold for statistical significance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Confirmatory qPCR for EDN1, PHACTR1, SIRT1, GFOD1, HIVEP1, and TBC1D7 used validated probes and HPRT1 as the reference gene.

    “Confirmatory qPCR conducted on EDN1, PHACTR1, SIRT1, GFOD1, HIVEP1, and TBC1D7 was assessed using validated probes, with HPRT1 as a reference gene.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Each ELISA experiment contained nine samples, comprising three independently differentiated clones each cultured in three wells.

    “Each experiment included 9 samples (3 independently differentiated clones, cultured in 3 wells each).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Three homozygous major and three homozygous minor clones were selected for subsequent study.

    “3 homozygous major and 3 homozygous minor clones were selected for further study.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Thirty-three plasma samples were selected for each genotype at rs9349379.

    “33 samples of each genotype at rs9349379 were selected.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    For each cell line, three wild-type and three biallelic 88-base-pair deletion clones were chosen for further experiments.

    “In each cell line, 3 wild-type and 3 biallelic 88 base pair deletions were selected for further study.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    Publicly available ChIP-seq datasets were used to corroborate the findings from iPSC-derived endothelial cells.

    “Publicly available ChIP-seq data were used to confirm findings from iPSC-ECs. (HUVEC, H3K27Ac ChIP-seq: GEO Data GSE53998; (Brown et al., 2014) iPSC/Embryonic-EC, H3K27Ac ChIP-seq: (GNomEx, Accession number: 195R2; (Theodoris et al., 2015)).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Brown et al., 2014

      Not checked in the free run.

    • cites Theodoris et al., 2015

      Not checked in the free run.

35 of 35
  • The paper relies on this without support.

    The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.

    “we performed genome-editing experiments inpluripotent stem cells, and we differentiated these cells into two vascular cell types: endothelial cells (ECs) and vascular smooth muscle cells (VSMCs).”
    “In both iPSC-derived ECs and VSMCs, loss of the 88 bp flanking rs9349379 resulted in higher expression of the endothelin-1 (EDN1) gene compared with wild-type lines (Figure 3B).”
  • The paper relies on this without support.

    A roughly 20% change in EDN1 expression caused by rs9349379 is large enough to influence risk of the five vascular diseases.

    “In this study, the cis-regulatory effect of the causal variant is a 20% increase in EDN1 expression in the genome-edited ECs homozygous for the G allele.”
    “In summary, we provide several lines of evidence that a common DNA variant associated with five vascular diseases regulates a gene, EDN1, located over 600 kb upstream in genomic distance.”
  • The paper relies on this without support.

    The common contact site about 300 kb from both EDN1 and rs9349379 is the route by which the distal regulatory effect on EDN1 occurs.

    “Instead, the data point to a common contact site approximately 300 kb from both the EDN1 promoter and rs9349379 regulatory element.”
    “The EDN1 locus may represent another example of such distal regulation, but further work is necessary to establish the mechanism by which the common contact site mediates gene expression.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Similar functional descriptions have been reported for individual loci implicated in schizophrenia, cardiovascular disease, type 2 diabetes and Alzheimer's disease.

    “Similar functional descriptions have been reported for individual loci implicated in schizo phrenia64, cardiovascular disease104, type 2 diabetes105 and Alzheimer’s disease106, among others.”

    From A brief history of human disease genetics (2020) · cites this paper as [104]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Flow-mediated dilation estimate falls outside its confidence interval

    Major

    The reported effect estimate of −0.1209 is outside the stated 95% confidence interval, whose endpoints are both below −0.55. The interval's endpoints are also printed in descending order.

  • Plasma-sample eligibility uses two different comorbidity scores

    Minor

    The results and assay methods specify a Charlson score of 0, but the human-subjects methods define the no-other-diagnoses criterion using an index of 1.

  • Listed qPCR target does not match the listed probe

    Minor

    The methods list SIRT1 among the qPCR targets but identify the corresponding listed SIRT probe as SIRT5.

  • Arterial-stiffness sample size differs between sections

    Minor

    The results give 38,817 participants, while the methods give 38,795 individuals for the arterial-stiffness analysis.

  • Human-plasma conclusion names a different SNP

    Minor

    The plasma analysis is described as testing rs9349379, but its concluding sentence names rs93493979.

  • Discussion switches the locus to the other chromosome arm

    Minor

    The discussion calls the distal regulatory locus 6q24, whereas the paper otherwise identifies the studied locus as 6p24.

6 of 6

The citation lists haven’t been fetched yet

References 76 · Cited by 450

Research works printed but not linked: 3

  1. Corretti, 2002, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force, J. Am. Coll. Cardiol., 39, 257, 10.1016/S0735-1097(01)01746-6 · DOI
  2. Olin, 2014, Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association, Circulation, 129, 1048, 10.1161/01.cir.0000442577.96802.8c · DOI
  3. Pollock, 2010, Dissecting the complex physiology of endothelin: new lessons from genetic models, Hypertension, 56, 31, 10.1161/HYPERTENSIONAHA.109.139758 · DOI

Authors
Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., Khera, A. V., Ryan, R. J. H., Engreitz, J. M., Issner, R., Shoresh, N., Epstein, C. B., de Laat, W., Brown, J. D., Schnabel, R. B., Bernstein, B. E., & Kathiresan, S.
Affiliations
  • Broad Institute (US)
  • University Medical Center Utrecht (NL)
  • University Medical Center Hamburg-Eppendorf (DE)
  • Vanderbilt University Medical Center (US)
Corresponding author
  • Gupta, Rajat M.
  • Kathiresan, Sekar
Venue
Cell
Publisher
Elsevier BV
Published
2017-07
Volume
170
Issue
3
Pages
522-533.e15
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2739458618
Cited by
450
References
76
Citations by year
2026: 23 · 2025: 35 · 2024: 50 · 2023: 44 · 2022: 56 · 2021: 50 · 2020: 63 · 2019: 61 · 2018: 54 · 2017: 12 · 2015: 1
FWCI
34.49
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
Funders
  • Sarnoff Scholar Award
  • Harvard Catalyst CMERIT Award
  • NIH (NHLBI K08-HL128810, T32 HL007734)
  • NIH NIDDK (R01 DK097768)
  • Fondation Leducq CVGeneF(x) Transatlantic Network of Excellence (R01HL127564)
  • Ofer and Shelly Nemirovsky MGH Research Scholar Award
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
Keywords
PHACTR1, endothelin-1, coronary artery disease, migraine, cervical artery dissection, fibromuscular dysplasia, hypertension, vascular disease, enhancers, non-coding variants, aorta, stem cell-derived endothelial cells
MeSH terms
Gene Editing, Acetylation, Cells, Cultured, Chromatin, Chromosome Mapping, Chromosomes, Human, Pair 6, Coronary Artery Disease, Histones, Humans, Muscle, Smooth, Vascular, Vascular Diseases, Gene Expression, Endothelin-1, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Endothelial Cells, Genome-Wide Association Study, Epigenomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review